Articles on Gene Patenting

We have put together a list of articles on gene patenting. It is still work in progress, although we have attempted to capture as many aspects of the debate as we could. If you have suggested readings to include, please email us or add them to the comments section below.

Abbott. Europe to pay royalties for cancer gene. Nature (2008)

Adler. Genome Research: Fulfilling the Public’s Expectations for Knowledge and Commercialization. ScienceNew Series (1992) vol. 257 (5072) pp. 908-914

Andrews. Genes and patent policy: rethinking intellectual property rights. Nature Reviews Genetics (2002)

ASKLAND. Patenting genes: A fast and furious primer. The International journal of applied philosophy (2003) vol. 17 (2) pp. 267-275

Balter. France Rebels against Gene-Patenting Law. ScienceNew Series (2000) vol. 288 (5474) pp. 2115

Bar-Shalom and Cook-Deegan. Patents and Innovation in Cancer Therapeutics: Lessons from CellPro. The Milbank Quarterly (2002) vol. 80 (4) pp. 637-676

Barton. The impact of contemporary patent law on plant biotechnology research. Intellectual Property Rights (1998) vol. 85

Bessen and Meurer. Do Patents Perform Like Property?. The Academy of Management Perspectives (formerly The Academy of Management Executive)(AMP) (2008) vol. 22 (3) pp. 8-20

Bolnick et al. Genetics: the science and business of genetic ancestry testing. Science (2007)

Butler and Goodman. French researchers take a stand against cancer gene patent. Nature (2001) vol. 413 (6852) pp. 95-96

Caplan and Merz. Patenting gene sequences. BMJ (1996) vol. 312 (7036) pp. 926-926

Caulfield et al. Evidence and anecdotes: an analysis of human gene patenting controversies. Nat Biotechnol (2006) vol. 24 pp. 1091-1094

Cole-Turner. Religion and Gene Patenting. ScienceNew Series (1995) vol. 270 (5233) pp. 52

Cook-Deegan and McCormack. Patents, Secrecy, and DNA. ScienceNew Series (2001) vol. 293 (5528) pp. 217

Crichton. Patenting Life – New York Times. New York Times (2007) pp. 1-2

Czarnetzky. Altering Nature’s Blueprints for Profit: Patenting Multicellular Animals. Virginia Law Review (1988) vol. 74 (7) pp. 1327-1362

Dalpé et al. Watching the Race to Find the Breast Cancer Genes. ScienceTechnology& Human Values (2003) vol. 28 (2) pp. 187-216

Dickson. Europe Tries to Untangle Laws on Patenting Life. ScienceNew Series (1989) vol. 243 (4894) pp. 1002-1003

D Nicol. Navigating the Molecular Diagnostic Patent Landscape (2008). Expert Opinion on Therapeutic Patents pp. 461-472

D Nicol. Biomedical Patents: Innovation and Access, Trust and Mistrust in M Stranger (ed) Human Biotechnology and Public Trust: Trends Perceptions and Regulation (Hobart: Centre for Law and Genetics Occasional Paper No 7; 2007) pp. 47-63

D Nicol. On the Legality of Gene Patents (2005) 29 Melbourne University Law Review pp. 809-842

D Nicol. Balancing Innovation and Access to Healthcare through the Patent System – An Australian Perspective (2005). Community Genetics pp.  228-234

D Nicol and J Nielsen. Australian Medical Biotechnology: Navigating a Complex Patent Landscape (2005) 27 European Intellectual Property Review pp. 313-318

D Nicol. Human Gene Patents: Under Whose Control? (2003) Medical Journal of Australia pp. 181-182

Doll. The Patenting of DNA. ScienceNew Series (1998) vol. 280 (5364) pp. 689-690

Eisenberg. How can you patent genes?. The American Journal of Bioethics (2002) vol. 2 (3) pp. 3-11

Enserink. Patent Office May Raise the Bar on Gene Claims. ScienceNew Series (2000) vol. 287 (5456) pp. 1196-1197

Feldman et al. Equity and the Technology Transfer Strategies of American Research Universities. Management Science (2002) vol. 48 (1) pp. 105-121

Fried et al. Patenting Genes. ScienceNew Series (1998) vol. 281 (5376) pp. 517

Gaglioti. Australian biotechnology company enforces cancer gene patent, restricting medical scanning.  (2009) pp. 1-3

Gallini. The Economics of Patents: Lessons from Recent U.S. Patent Reform. The Journal of Economic Perspectives (2002) vol. 16 (2) pp. 131-154

Gittelman. A Note on the Value of Patents as Indicators of Innovation: Implications for Management Research. The Academy of Management Perspectives (formerly The Academy of Management Executive)(AMP) (2008) vol. 22 (3) pp. 21-27

Gold. Moving the gene patent debate forward. Nat Biotechnol (2000) vol. 18 pp. 1319-1320

Grisham. New rules for gene patents’. Nat Biotechnol (2000) vol. 18 (9) pp. 921

Hanson. Special Supplement: Religious Voices in Biotechnology: The Case of Gene Patenting. The Hastings Center Report (1997) vol. 27 (6) pp. 1-20

Heller and Eisenberg. Can Patents Deter Innovation? The Anticommons in Biomedical Research. ScienceNew Series (1998) vol. 280 (5364) pp. 698-701

Henry et al. DNA Patenting and Licensing. ScienceNew Series (2002) vol. 297 (5585) pp. 1279

Himma. Justifying legal protection of intellectual property: the interests argument. SIGCAS Computers and Society (2008) vol. 38 (4)

Hsu, D. and Lim, K., 2006. The Antecedents and Innovation Consequences of Knowledge Brokering Capability, IPRIA, MBS  and Wharton working paper.

Huang, K.G. and F.E. Murray (2008) “Does Patent Strategy Shape the Long-run Supply of Public Knowledge? Evidence from Human Genetics.” Forthcoming, Academy of Management Journal.

Hughes. Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980. Isis (2001) vol. 92 (3) pp. 541-575

Jackson. Innovation and Intellectual Property: The Case of Genomic Patenting. Journal of Policy Analysis and Management (2003) vol. 22 (1) pp. 5-25

Jensen and Murray. INTELLECTUAL PROPERTY: Enhanced: Intellectual Property Landscape of the Human Genome. Science (2005) vol. 310 (5746) pp. 239-240

Kaiser. Patent Sprawl: From Genes to Gene Interpretation. ScienceNew Series (2003) vol. 302 (5652) pp. 1878

Lee. Patents, Paradigm Shifts, and Progress in Biomedical Science. The Yale Law Journal (2004) vol. 114 (3) pp. 659-695

Lei et al. Patents versus patenting: implications of intellectual property protection for biological research. Nat Biotechnol (2009) vol. 27 (1) pp. 36-40

Lei et al. Patents versus patenting: implications of intellectual property protection for biological research.  (2009)

Lovgren. One-Fifth of Human Genes Have Been Patented,
Study Reveals. National Geographic News  (2005) pp. 1-2

Luigi. [BOOK] … Materials in the Context of the Agreement on Trade-related Aspects of Intellectual Property Rights
. University of New South Wales (2004)

MacKenzie et al. Patents and Free Scientific Information in Biotechnology: Making Monoclonal Antibodies Proprietary. ScienceTechnology& Human Values (1990) vol. 15 (1) pp. 65-83

Mann et al. Open access publishing in science. Communications of the ACM (2009) vol. 52 (3)

Marshall et al. In the Crossfire: Collins on Genomes, Patents, and ‘Rivalry’. ScienceNew Series (2000) vol. 287 (5462) pp. 2396-2398

Marshall. Snipping Away at Genome Patenting. ScienceNew Series (1997) vol. 277 (5333) pp. 1752-1753

Marshall. A Showdown Over Gene Fragments. ScienceNew Series (1994) vol. 266 (5183) pp. 208+209-210

Marshall. ‘Playing Chicken’ Over Gene Markers. ScienceNew Series (1997) vol. 278 (5346) pp. 2046-2048

Matthijs and Hodgson. The impact of patenting on DNA diagnostic practice. Clinical medicine (London, England) (2008) vol. 8 (1) pp. 58-60

Merz et al. Diagnostic testing fails the test. Nature (2002) vol. 415 (6872) pp. 577-579

Merz and Henry. The prevalence of patent interferences in gene technology. Nat Biotechnol (2004) vol. 22 (2) pp. 153-154

Merz et al. Disease gene patenting is a bad innovation. Molecular Diagnosis (1997) vol. 2 (4) pp. 299-304

Morton. Genetic Epidemiology, Genetic Maps and Positional Cloning. Philosophical Transactions: Biological Sciences (2003) vol. 358 (1438) pp. 1701-1708

Nelson. The Advance of Technology and the Scientific Commons. Philosophical Transactions: Mathematical Physical and Engineering Sciences (2003) vol. 361 (1809) pp. 1691-1708

Nicol et al. Patents and medical biotechnology: An empirical analysis of issues facing the Australian industry.  (2003)

Palombi. Beyond Recombinant Technology: Synthetic Biology and Patentable Subject Matter. Luigi Palombi (2008)

Palombi. Improving Access To Medicines Doesn’t Have To Mean More Patents. Luigi Palombi (2008)

Palombi. The patenting of biological materials in the context of TRIPS. Luigi Palombi (2004) pp. 4

Peitsch. Grid Computing in Drug Discovery. Cluster Computing and the Grid, 2006. CCGRID 06. Sixth IEEE International Symposium on (2006) vol. 1 pp. 3 – 3

Plahe and Nyland. The WTO and Patenting of Life Forms: Policy Options for Developing Countries. Third World Quarterly (2003) vol. 24 (1) pp. 29-45

Rabino. Ethical Debates in Genetic Engineering: U.S. Scientists’ Attitudes on Patenting, Germ-Line Research, Food Labeling, and Agri-Biotech Issues. Politics and the Life Sciences (1998) vol. 17 (2) pp. 147-163

Resnik. DNA patents and scientific discovery and innovation: assessing benefits and risks. Science and Engineering Ethics (2001)

Reynolds. Gene patent race speeds ahead amid controversy, concern. JNCI (2000) vol. 92 (3) pp. 184-186

Roberts. NIH Gene Patents, Round Two. ScienceNew Series (1992) vol. 255 (5047) pp. 912-913

Schatz. The Swiss Vote on Gene Technology. ScienceNew Series (1998) vol. 281 (5384) pp. 1810-1811

Scherer. The economics of human gene patents. Academic medicine : journal of the Association of American Medical Colleges (2002) vol. 77 (12 Pt 2) pp. 1348-67

Schmidt. Indi-GENE-ous Conflicts. Environmental Health Perspectives (2001) vol. 109 (5) pp. A216-A219

Service. Gene and Protein Patents Get Ready to Go Head to Head. ScienceNew Series (2001) vol. 294 (5549) pp. 2082-2083

Sevilla et al. Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. International journal of technology assessment in health … (2003)

Shear and Kelley. A Researcher’s Guide to Patents. Plant Physiology (2003) vol. 132 (3) pp. 1127-1130

Stokes. In the Literature: Qualms about Patenting Human Genes. The Hastings Center Report (2001) vol. 31 (1) pp. 7

Stone. Sweeping Patents Put Biotech Companies on the Warpath. ScienceNew Series (1995) vol. 268 (5211) pp. 656-658

Taubes. Scientists Attacked for ‘Patenting’ Pacific Tribe. ScienceNew Series (1995) vol. 270 (5239) pp. 1112

Trudinger. Gene patent system ain’t broke, but needs fine tuning_ ALRC – Australian Life Scientist.  (2009) pp. 1-4

Unknown. Patenting Biology: DNA and Oil-Eaters. Science News (1978) vol. 113 (11) pp. 167+175

Unknown. Report to the European Commission: Ethical Aspects of Patenting Inventions Involving Elements of Human Origin. Group of Advisers on the Ethical Implications of Biotechnology. Politics and the Life Sciences (1997) vol. 16 (1) pp. 139-141

Wade. University and Drug Firm Battle over Billion-Dollar Gene. ScienceNew Series (1980) vol. 209 (4464) pp. 1492-1494

Wade. Supreme Court Hears Argument on Patenting Life Forms. ScienceNew Series (1980) vol. 208 (4439) pp. 31-32

Williams-Jones. History of a gene patent: tracing the development and application of commercial BRCA testing. Health Law Journal (2002) vol. 10 pp. 123-146

Ziedonis. On the Apparent Failure of Patents: A Response to Bessen and Meurer. The Academy of Management Perspectives (formerly The Academy of Management Executive)(AMP) (2008) vol. 22 (4) pp. 21-29

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s